St. Jude Children's Research Hospital investigators have collaborated with a global group of acute pediatric critical illness experts to reach a consensus definition of the condition. Research on how to improve care in low- ...
Jan 8, 2024
0
0
A study from St. Jude Children's Research Hospital sheds light on the incidence of prediabetes and diabetes in childhood cancer survivors for better prevention and treatment. At a younger age, childhood cancer survivors can ...
Dec 13, 2023
0
0
Hyperdiploidy is a genetic condition observed in cancer cells, where the cells contain more chromosomes than usual. The condition is particularly prevalent in childhood B-cell acute lymphoblastic leukemia (B-ALL), the most ...
Sep 20, 2023
0
1
To gain a clearer understanding of the differences between childhood cancer patients when it comes to the impact of radiation therapy on cognition, scientists at St. Jude Children's Research Hospital studied the effect of ...
Apr 28, 2023
0
25
A report from the Childhood Cancer Survivor Study (CCSS) provides strong evidence of the importance of a healthy lifestyle for adults who were treated for cancer as children. The study is the first to find that the specific ...
Apr 6, 2023
0
16
Childhood cancer survivors who experience health equity issues, such as a lack of health insurance or education, are also more likely to have a higher burden of severe symptoms as adults. The study from scientists at St. ...
Sep 28, 2022
0
4
"Why did my child get cancer?"
Sep 8, 2022
0
35
More-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic leukemia (T-ALL). St. Jude Children's Research Hospital scientists have leveraged the latest chemical technology ...
Aug 24, 2022
0
19
Scientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their new simplified approach selected for an advantageous T-cell type and showed promise in the lab against ...
Aug 5, 2022
0
39
Scientists at St. Jude Children's Research Hospital developed a strategy to improve the ability of engager (ENG) T cells to kill acute myeloid leukemia (AML). The approach showed promise in preclinical models against hard-to-treat ...
Jul 29, 2022
0
5
